Predictors of persistence of post-chemotherapy symptoms among survivors of solid tumor cancers.

Chemotherapy Post-treatment symptom management Quality of life Risk factors Symptom burden

Journal

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
ISSN: 1573-2649
Titre abrégé: Qual Life Res
Pays: Netherlands
ID NLM: 9210257

Informations de publication

Date de publication:
30 Jan 2024
Historique:
accepted: 21 12 2023
medline: 31 1 2024
pubmed: 31 1 2024
entrez: 30 1 2024
Statut: aheadofprint

Résumé

Late or residual symptoms diminish quality of life for many cancer survivors after completion of treatment. Examine risk factors associated with persisting symptom burden after chemotherapy and the lack of symptom improvement over time. Survivors who completed curative-intent chemotherapy within two years for solid tumors were enrolled into a symptom management trial. There were 375 survivors with two or more comorbid conditions or one comorbid condition and elevated depressive symptoms (pre-defined risk factors in the trial design) who received interventions and 71 survivors without these risk factors who did not receive interventions. For all survivors, symptoms were assessed at intake, 4, and 13 weeks and categorized as mild, moderate, or severe based on the interference with daily life. The probabilities of moderate or severe symptoms and symptom improvement were analyzed using generalized mixed-effects models in relation to comorbidity, depressive symptoms, age, sex, race/ethnicity, employment, time since chemotherapy completion, and physical function. Multiple symptoms were treated as nested within the survivor. Moderate or severe symptoms at baseline and the lack of improvement over time were associated with younger age and lower physical function over and above a greater number of comorbidities and elevated severity of depressive symptoms. Risk factors identified in this research (younger age, lower physical function, greater comorbidity, and higher depressive symptoms) can be used to allocate resources for post-treatment symptom management for cancer survivors in order to relieve symptoms that do not necessarily resolve with time.

Identifiants

pubmed: 38291312
doi: 10.1007/s11136-023-03595-8
pii: 10.1007/s11136-023-03595-8
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NCI NIH HHS
ID : R01 CA225615-01
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA023074
Pays : United States

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Références

Cleeland, C., Zhao, F., Chang, V., et al. (2013). The symptom burden of cancer: Evidence for a core set of cancer-related and treatment-related symptoms from the eastern cooperative oncology group symptom outcomes and practice patterns study. Cancer, 119(24), 4333–4340. https://doi.org/10.1002/cncr.28376
doi: 10.1002/cncr.28376 pubmed: 24114037
Portenoy, R. K., Thaler, H. T., Kornblith, A. B., et al. (1994). Symptom prevalence, characteristics and distress in a cancer population. Quality of Life Research, 3(3), 183–189.
doi: 10.1007/BF00435383 pubmed: 7920492
Kim, S. H., Kim, K., & Mayer, D. K. (2017). Self-management intervention for adult cancer survivors after treatment: a systematic review and meta-analysis. Oncology Nursing Forum, 44(6), 719–728. https://doi.org/10.1188/17.ONF.719-728
doi: 10.1188/17.ONF.719-728 pubmed: 29052663
Faul, L. A., Jim, H. S., Williams, C., Loftus, L., & Jacobsen, P. B. (2010). Relationship of stress managment skills to psychological distress and quality of life in adults with cancer. Psycho Oncology., 19(1), 102–109.
doi: 10.1002/pon.1547 pubmed: 19253915
Jacobs, J. M., Ream, M. E., Pensak, N., et al. (2019). Patient experiences with oral chemotherapy: adherence, symptoms, and quality of life. Journal of the National Comprehensive Cancer Network, 17(3), 221–228. https://doi.org/10.6004/jnccn.2018.7098
doi: 10.6004/jnccn.2018.7098 pubmed: 30865917 pmcid: 6626621
Ganz, P., Kwan, L., Stanton, A., Krupnick, J., Rowland, J. H., & Meyerowitz, B. (2004). Quality of life at the end of primary treatment of breast cancer: First results from the moving beyond cancer randomized trial. Journal of the National Cancer Institute, 96(5), 376–387.
doi: 10.1093/jnci/djh060 pubmed: 14996859
Ganz, P. A., Kwan, L., Stanton, A. L., Bower, J. E., & Belin, T. R. (2011). Physical and psychosocial recovery in the year after primary treatment of breast cancer. Journal of Clinical Oncology, 29(9), 1101–1109. https://doi.org/10.1200/JCO.2010.28.8043
doi: 10.1200/JCO.2010.28.8043 pubmed: 21300931 pmcid: 3083865
Post, K. E. F. J. (2016). Web based survivorship interventions for women with breast cancer: An integrative review. European Journal of Oncology Nursing, 25, 90–99. https://doi.org/10.1016/j.ejon.2016.10.004
doi: 10.1016/j.ejon.2016.10.004 pubmed: 27865259
Ferrell, B. R., Dow, K. H., & Grant, M. (1995). Measurement of the quality of life in cancer survivors. Quality of Life Research, 4(6), 523–531. https://doi.org/10.1007/BF00634747
doi: 10.1007/BF00634747 pubmed: 8556012
Boivin, M. J., Sikorskii, A., Haan, P., et al. (2021). Health-related quality of life: longitudinal analysis from the time of breast biopsy into the post-treatment period. Front Glob Womens Health, 2, 608787. https://doi.org/10.3389/fgwh.2021.608787
doi: 10.3389/fgwh.2021.608787 pubmed: 34816181 pmcid: 8593952
Given, C. W., Given, B., Azzouz, F., Kozachik, S., & Stommel, M. (2001). Predictors of pain and fatigue in the year following diagnosis among elderly cancer patients. Journal of Pain and Symptom Management, 21(6), 456–466. https://doi.org/10.1016/s0885-3924(01)00284-6
doi: 10.1016/s0885-3924(01)00284-6 pubmed: 11397603
Dougherty, P., Cata, J., Cordella, J., Burton, A., & Weng, H. (2004). Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients. Pain, 109, 132–142.
doi: 10.1016/j.pain.2004.01.021 pubmed: 15082135
Mercadante, S., Casuccio, A., & Fulfaro, F. (2000). The course of symptom frequency and intensity in advanced cancer patients followed at home. Journal of Pain and Symptom Management, 20(2), 104–112.
doi: 10.1016/S0885-3924(00)00160-3 pubmed: 10989248
Dupont, A., Bower, J. E., Stanton, A. L., & Ganz, P. A. (2013). Cancer-related intrusive thoughts predict behavioral symptoms following breast cancer treatment. Health Psychology. https://doi.org/10.1037/a0031131
doi: 10.1037/a0031131 pubmed: 23379385 pmcid: 3796187
Jansen, C. E., Miaskowski, C., Dodd, M., Dowling, G., & Kramer, J. (2005). A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function. Cancer, 104(10), 2222–2233. https://doi.org/10.1002/cncr.21469
doi: 10.1002/cncr.21469 pubmed: 16206292
Carreira, H., Williams, R., Müller, M., Harewood, R., Stanway, S., & Bhaskaran, K. (2018). Associations between breast cancer survivorship and adverse mental health outcomes: a systematic review. Journal of the National Cancer Institute, 110(12), 1311–1327. https://doi.org/10.1093/jnci/djy177
doi: 10.1093/jnci/djy177 pubmed: 30403799 pmcid: 6292797
Costa, D. S. J., & Fardell, J. E. (2019). Why are objective and perceived cognitive function weakly correlated in patients with cancer? Journal of Clinical Oncology, 37(14), 1154–1158. https://doi.org/10.1200/JCO.18.02363
doi: 10.1200/JCO.18.02363 pubmed: 30920881
Kroenke, K. (2001). Studying symptoms: Sampling and measurement issues. Annals of internal medicine, 134(9 Pt 2), 844–853.
doi: 10.7326/0003-4819-134-9_Part_2-200105011-00008 pubmed: 11346320
Wilson, I. B., & Cleary, P. D. (1995). Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA, 273(1), 59–65.
doi: 10.1001/jama.1995.03520250075037 pubmed: 7996652
Misono, S., Weiss, N. S., Fann, J. R., Redman, M., & Yueh, B. (2008). Incidence of suicide in persons with cancer. Journal of clinical oncology : Official journal of the American Society of Clinical Oncology, 26(29), 4731–4738.
doi: 10.1200/JCO.2007.13.8941 pubmed: 18695257
Fann, J. R., Thomas-Rich, A. M., Katon, W. J., et al. (2008). Major depression after breast cancer: A review of epidemiology and treatment. General hospital psychiatry, 30(2), 112–126.
doi: 10.1016/j.genhosppsych.2007.10.008 pubmed: 18291293
Jahan, N., Cathcart-Rake, E. J., & Ruddy, K. J. (2022). Late breast cancer survivorship: side effects and care recommendations. Journal of Clinical Oncology, 40(15), 1604–1610. https://doi.org/10.1200/JCO.22.00049
doi: 10.1200/JCO.22.00049 pubmed: 35226513 pmcid: 9113203
Badger, T. A., Sikorskii, A., Segrin, C., Crane, T. E., & Hadeed, M. (2020). Symptom Management and Survivorship Handbook (2nd ed.). University of Arizona College of Nursing.
Korn, C. W., Sharot, T., Walter, H., Heekeren, H. R., & Dolan, R. J. (2014). Depression is related to an adsence fo optimistically baiased belief updating about future life events. Psychological Medicine, 44(3), 579–592. https://doi.org/10.1017/S0033291713001074
doi: 10.1017/S0033291713001074 pubmed: 23672737
Dozois, D. J., & Dobson, K. S. (2001). Information processing and colgnitive organization in unipolar depression: Specificity and comorbidity issues. Journal of Abnormal Psychology, 110(2), 236–246.
doi: 10.1037/0021-843X.110.2.236 pubmed: 11358018
Hjerl, K., Andersen, E. W., Keiding, N., Mortensen, P. B., & Jorgensen, T. (2002). Increased incidence of affective disorders, anxiety disorders, and non-natural mortality in women after breast cancer diagnosis: A nation-wide cohort study in Denmark. Acta Psychiatrica Scandinavica, 105(4), 258–264.
doi: 10.1034/j.1600-0447.2002.9028.x pubmed: 11942929
Zhu, L., Ranchor, A. V., van der Lee, M., et al. (2017). Co-morbidity of depression, anxiety and fatigue in cancer patients receiving psychological care. Psycho-Oncology, 26(4), 444–451. https://doi.org/10.1002/pon.4153
doi: 10.1002/pon.4153 pubmed: 27193933
Bayliss, E. A., Ellis, J. L., & Steiner, J. F. (2007). Barriers to self-management and quality-of-life outcomes in seniors with multimorbidities. Annals of Family Medicine, 5(5), 395–402.
doi: 10.1370/afm.722 pubmed: 17893380 pmcid: 2000313
Bender, C. M., Engberg, S. J., Donovan, H. S., et al. (2008). Symptom clusters in adults with chronic health problems and cancer as a comorbidity. Oncology Nursing Forum, 35(1), E1–E11.
doi: 10.1188/08.ONF.E1-E11 pubmed: 18192145 pmcid: 2842123
Das, S. C., Khurana, H., Gupta, D., Mishra, S., & Bhatnagar, S. (2009). Comorbidities in a cancer patient: Problems in pain management and palliation. The American Journal of Hospice & Palliative Care, 26(1), 60–63. https://doi.org/10.1177/1049909108322297
doi: 10.1177/1049909108322297
Gerbershagen, H. J., Ozgur, E., Straub, K., et al. (2008). Prevalence, severity, and chronicity of pain and general health-related quality of life in patients with localized prostate cancer. European journal of pain (London, England), 12(3), 339–350. https://doi.org/10.1016/j.ejpain.2007.07.006
doi: 10.1016/j.ejpain.2007.07.006 pubmed: 17855135
Harlan, L. C., Klabunde, C. N., Ambs, A. H., et al. (2009). Comorbidities, therapy, and newly diagnosed conditions for women with early stage breast cancer. Journal of Cancer Survivorship, 3(2), 89–98. https://doi.org/10.1007/s11764-009-0084-3
doi: 10.1007/s11764-009-0084-3 pubmed: 19437121 pmcid: 2998176
Harris, E. E., Hwang, W. T., Urtishak, S. L., Plastaras, J., Kinosian, B., & Solin, L. J. (2008). The impact of comorbidities on outcomes for elderly women treated with breast-conservation treatment for early-stage breast cancer. International Journal of Radiation Oncology Biology Physics, 70(5), 1453–1459. https://doi.org/10.1016/j.ijrobp.2007.08.059
doi: 10.1016/j.ijrobp.2007.08.059 pubmed: 17980504
Pinkawa, M., Fischedick, K., Gagel, B., et al. (2009). Impact of age and comorbidities on health-related quality of life for patients with prostate cancer: evaluation before a curative treatment. BMC Cancer. https://doi.org/10.1186/1471-2407-9-296
doi: 10.1186/1471-2407-9-296 pubmed: 19703300 pmcid: 2739535
Cleeland, C. S. (2007). Symptom burden: Multiple symptoms and their impact as patient-reported outcomes. Journal of the National Cancer Institute Monographs, 37, 16–21. https://doi.org/10.1093/jncimonographs/lgm005
doi: 10.1093/jncimonographs/lgm005
Ahern, T. P., Lash, T. L., Thwin, S. S., & Silliman, R. A. (2009). Impact of acquired comorbidities on all-cause mortality rates among older breast cancer survivors. Medical Care, 47(1), 73–79. https://doi.org/10.1097/MLR.0b013e318180913c
doi: 10.1097/MLR.0b013e318180913c pubmed: 19106734 pmcid: 2933563
Aschele, C., Bergamo, F., & Lonardi, S. (2009). Chemotherapy for operable and advanced colorectal cancer. Cancer treatment review., 35(6), 509–516. https://doi.org/10.1016/j.ctrv.2009.04.003
doi: 10.1016/j.ctrv.2009.04.003
Kelly, D. (2006). Delays in the diagnosis of lung cancer occurred because patients failed to recognise symptoms as serious and warranting medical attention. Evidence-based nursing, 9(4), 127.
doi: 10.1136/ebn.9.4.127 pubmed: 17076027
Miller, A. H., Ancoli-Israel, S., Bower, J. E., Capuron, L., & Irwin, M. R. (2008). Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. Journal of Clinical Oncology, 26(6), 971–982. https://doi.org/10.1200/jco.2007.10.7805
doi: 10.1200/jco.2007.10.7805 pubmed: 18281672
Mukerji, S. S., Duffy, S. A., Fowler, K. E., Khan, M., Ronis, D. L., & Terrell, J. E. (2007). Comorbidities in head and neck cancer: agreement between self-report and chart review. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery., 136(4), 536–542. https://doi.org/10.1016/j.otohns.2006.10.041
doi: 10.1016/j.otohns.2006.10.041 pubmed: 17418247
Ozanne, E. M., Braithwaite, D., Sepucha, K., Moore, D., Esserman, L., & Belkora, J. (2009). Sensitivity to input variability of the Adjuvant! Online breast cancer prognostic model. Journal of Clinical Oncology, 27(2), 214–219. https://doi.org/10.1200/jco.2008.17.3914
doi: 10.1200/jco.2008.17.3914 pubmed: 19047286
Perkins, H. Y., Baum, G. P., Taylor, C. L., & Basen-Engquist, K. M. (2009). Effects of treatment factors, comorbidities and health-related quality of life on self-efficacy for physical activity in cancer survivors. Psycho-Oncology, 18(4), 405–411. https://doi.org/10.1002/pon.1535
doi: 10.1002/pon.1535 pubmed: 19241489 pmcid: 9578562
Siegelmann-Danieli, N., Khandelwal, V., Wood, G. C., et al. (2006). Breast cancer in elderly women: Outcome as affected by age, tumor features, comorbidities, and treatment approach. Clinical Breast Cancer, 7(1), 59–66. https://doi.org/10.3816/CBC.2006.n.014
doi: 10.3816/CBC.2006.n.014 pubmed: 16764745
Hewitt, M., Greenfield, S., & Stovall, E. (2005). From Cancer Patient to Cancer Survivor: Lost in Translation. The National Academies Press.
Rowland, J. H., & Yancik, R. (2006). Cancer survivorship: The interface of aging, comorbidity, and quality care. Journal of the National Cancer Institute, 98(8), 504–505. https://doi.org/10.1093/jnci/djj154
doi: 10.1093/jnci/djj154 pubmed: 16622113
Parikh, R. B., Gallo, J. J., Wong, Y. N., et al. (2021). Long-term depression incidence and associated mortality among African American and White prostate cancer survivors. Cancer, 127(18), 3476–3485. https://doi.org/10.1002/cncr.33656
doi: 10.1002/cncr.33656 pubmed: 34061986
Bensken, W. P., Schiltz, N. K., Warner, D. F., et al. (2022). Comparing the association between multiple chronic conditions, multimorbidity, frailty, and survival among older patients with cancer. Journal of Geriatric Oncology, 13(8), 1244–1252. https://doi.org/10.1016/j.jgo.2022.06.011
doi: 10.1016/j.jgo.2022.06.011 pubmed: 35786369 pmcid: 9798334
Sikorskii, A., Badger, T., Segrin, C., et al. (2023). A sequential multiple assignment randomized trial of symptom management after chemotherapy. Journal of Pain Symptom Management, 65(6), 541-552 e2. https://doi.org/10.1016/j.jpainsymman.2023.02.005
doi: 10.1016/j.jpainsymman.2023.02.005 pubmed: 36801353
Hjerl, K., Andersen, E. W., Keiding, N., Mouridsen, H. T., Mortensen, P. B., & Jorgensen, T. (2003). Depression as a prognostic factor for breast cancer mortality. Psychosomatics, 44(1), 24–30. https://doi.org/10.1176/appi.psy.44.1.24
doi: 10.1176/appi.psy.44.1.24 pubmed: 12515834
Badger, T. A., Segrin, C., Hepworth, J. T., Pasvogel, A., Weihs, K., & Lopez, A. M. (2013). Telephone-delivered health education and interpersonal counseling improve quality of life for Latinas with breast cancer and their supportive partners. Psycho-Oncology, 22(5), 1035–1042. https://doi.org/10.1002/pon.3101
doi: 10.1002/pon.3101 pubmed: 22573418
Badger, T. A., Segrin, C., Sikorskii, A., et al. (2020). Randomized controlled trial of supportive care interventions to manage psychological distress and symptoms in Latinas with breast cancer and their informal caregivers. Psychology & Health, 35(1), 87–106. https://doi.org/10.1080/08870446.2019.1626395
doi: 10.1080/08870446.2019.1626395
Badger, T., Segrin, C., Figueredo, A. J., Harrington, J., Sheppard, K., Passalacqua, S., Pasvogel, A., & Bishop, M. (2012). Who benefits from a psychosocial counseling vs. educational intervention to improve psychological quality of life in prostate cancer surviors. Psychology & Health. https://doi.org/10.1080/08870446.2012.731058
doi: 10.1080/08870446.2012.731058
Bayliss, E., Ellis, J., & Steiner, J. (2009). Seniors’ self-reported multimorbidity captured biopsychosocial factors not incorporated into tow other data-based mortlity measures. Journal of Clinical Epidemiology, 62(5), 550–557.
doi: 10.1016/j.jclinepi.2008.05.002 pubmed: 18757178
Badger, T. A., Segrin, C., & Meek, P. (2011). Development and validation of an instrument to rapidly assess symptoms: The General Symptom Distress Scale. Journal of pain and symptom management, 41(3), 535–548.
doi: 10.1016/j.jpainsymman.2010.06.011 pubmed: 21131168
Given, B., Given, C., Sikorskii, A., et al. (2008). Establishing mild, moderate and severe scores for cancer related symptoms: How consistent and clinically meaningful are interference based severity cut points? Journal of Pain and Symptom Management, 35(2), 126–135.
doi: 10.1016/j.jpainsymman.2007.03.012 pubmed: 18158231
Jeon, S., GC, W., Sikorskii, A., & Given, B. (2009). Do interference-based cut-points differentiate mild, moderate, and severe levels of 16 cancer-related symptoms over time? Journal of Pain and Symptom Managemnt, 37(2), 220–232.
doi: 10.1016/j.jpainsymman.2008.01.010
Sikorskii, A., Given, C., You, M., Jeon, S., & Given, B. (2009). Response analysis for multiple symptoms revealed differences between arms of a symptom management trial. Journal of Clinical Epidemiology, 62(7), 716–724.
doi: 10.1016/j.jclinepi.2008.09.007 pubmed: 19124223 pmcid: 2743381
Radloff, L. S. (1977). The CES-D Scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1(3), 385–401.
doi: 10.1177/014662167700100306
Miaskowski, C., Mastick, J., Paul, S., Wallhagen, M., Abrams, G., & Levine, J. D. (2022). Associations among hearing loss, multiple co-occurring symptoms, and quality of life outcomes in cancer survivors. Journal of Cancer Survivorship. https://doi.org/10.1007/s11764-022-01301-0
doi: 10.1007/s11764-022-01301-0 pubmed: 36454519 pmcid: 9714406
Badger, T. A., Segrin, C., Crane, T. E., et al. (2023). Social determinants of health and symptom burden during cancer treatment. Nursing Research, 72(2), 103–113. https://doi.org/10.1097/NNR.0000000000000636
doi: 10.1097/NNR.0000000000000636 pubmed: 36729777
Schuz, N., Walters, J. A., Cameron-Tucker, H., Scott, J., Wood-Baker, R., & Walters, E. H. (2015). Patient anxiety and depression moderate the effects of increased self-management knowledge on physical activity: A secondary analysis of a randomised controlled trial on health-mentoring in COPD. COPD, 12(5), 502–509. https://doi.org/10.3109/15412555.2014.995289
doi: 10.3109/15412555.2014.995289 pubmed: 25774660
Campbell, G., Hagan, T., Gilbertson-White, S., Houze, M., & Donovan, H. (2016). Cancer and treatment-related symptoms are associated with mobility disability in women with ovarian cancer: A cross-sectional study. Gynecologic Oncology, 143(3), 578–583. https://doi.org/10.1016/j.ygyno.2016.09.013
doi: 10.1016/j.ygyno.2016.09.013 pubmed: 27653982 pmcid: 5116395
Iovino, P., De Maria, M., Matarese, M., Vellone, E., Ausili, D., & Riegel, B. (2020). Depression and self-care in older adults with multiple chronic conditions: A multivariate analysis. Journal of Advanced Nursing, 76(7), 1668–1678. https://doi.org/10.1111/jan.14385
doi: 10.1111/jan.14385 pubmed: 32281683
Ream, E., Hughes, A. E., Cox, A., et al. (2020). Telephone interventions for symptom management in adults with cancer. Cochrane Database System Review. https://doi.org/10.1002/14651858.CD007568.pub2
doi: 10.1002/14651858.CD007568.pub2
Deshields, T. L., Potter, P., Olsen, S., & Liu, J. (2014). The persistence of symptom burden: Symptom experience and quality of life of cancer patients across one year. Supportive Care in Cancer, 22(4), 1089–1096. https://doi.org/10.1007/s00520-013-2049-3
doi: 10.1007/s00520-013-2049-3 pubmed: 24292095
Cataldo, J. K., Paul, S., Cooper, B., et al. (2013). Differences in the symptom experience of older versus younger oncology outpatients: a cross-sectional study. BMC Cancer. https://doi.org/10.1186/1471-2407-13-6
doi: 10.1186/1471-2407-13-6 pubmed: 23281602 pmcid: 3576303
Hansen, M. B., Ross, L., Petersen, M. A., & Groenvold, M. (2022). Age, cancer site and gender associations with symptoms and problems in specialised palliative care: A large, nationwide, register-based study. BMJ supportive & palliative care, 12(e2), e201–e210. https://doi.org/10.1136/bmjspcare-2019-001880
doi: 10.1136/bmjspcare-2019-001880
Fredholm, H., Magnusson, K., Lindström, L. S., et al. (2016). Long-term outcome in young women with breast cancer: A population-based study. Breast Cancer Research and Treatment, 160(1), 131–143. https://doi.org/10.1007/s10549-016-3983-9
doi: 10.1007/s10549-016-3983-9 pubmed: 27624330 pmcid: 5050247
Farrar, J. T., Portenoy, R. K., Berlin, J. A., Kinman, J. L., & Strom, B. L. (2000). Defining the clinically important difference in pain outcome measures. Pain, 88(3), 287–294.
doi: 10.1016/S0304-3959(00)00339-0 pubmed: 11068116
Miaskowski, C., Dodd, M., West, C., et al. (2007). The use of a responder analysis to identify differences in patient outcomes following a self-care intervention to improve cancer pain management. Pain, 129(1–2), 55–63. https://doi.org/10.1016/j.pain.2006.09.031
doi: 10.1016/j.pain.2006.09.031 pubmed: 17257753 pmcid: 1906700
Sikorskii, A., Niyogi, P. G., Victorson, D., Tamkus, D., & Wyatt, G. (2020). Symptom response analysis of a randomized controlled trial of reflexology for symptom management among women with advanced breast cancer. Supportive Care in Cancer, 28(3), 1395–1404. https://doi.org/10.1007/s00520-019-04959-y
doi: 10.1007/s00520-019-04959-y pubmed: 31267277
Given, C., Given, B., Rahbar, M., et al. (2004). Effect of a cognitive behavioral intervention on reducing symptom severity during chemotherapy. Journal of Clinical Oncology., 22(3), 507–516.
doi: 10.1200/JCO.2004.01.241 pubmed: 14752074
Runowicz, C. D., Leach, C. R., Henry, N. L., et al. (2016). American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. CA Cancer J Clin. Jan-Feb, 66(1), 43–73. https://doi.org/10.3322/caac.21319
doi: 10.3322/caac.21319
Penedo, F. J., Medina, H. N., Moreno, P. I., et al. (2022). Implementation and feasibility of an electronic health record-integrated patient-reported outcomes symptom and needs monitoring pilot in ambulatory oncology. JCO Oncol Pract. https://doi.org/10.1200/OP.21.00706
doi: 10.1200/OP.21.00706 pubmed: 35290096 pmcid: 9287298
Basch, E., Barbera, L., Kerrigan, C. L., & Velikova, G. (2018). Implementation of patient-reported outcomes in routine medical care. American Society of Clinical Oncology Educational Book, 38, 122–134. https://doi.org/10.1200/EDBK_200383
doi: 10.1200/EDBK_200383 pubmed: 30231381
Tam, S., Zatirka, T., Neslund-Dudas, C., et al. (2023). Real time patient-reported outcome measures in patients with cancer: Early experience within an integrated health system. Cancer medicine. https://doi.org/10.1002/cam4.5635
doi: 10.1002/cam4.5635 pubmed: 37740609 pmcid: 10587968
Corser, W., Sikorskii, A., Olomu, A., Stommel, M., Proden, C., & Holmes-Rovner, M. (2008). Concordance between comorbidity data from patient self-report interviews and medical record documentation. BMC Health Services Research. https://doi.org/10.1186/1472-6963-8-85
doi: 10.1186/1472-6963-8-85 pubmed: 18416841 pmcid: 2346463
Ye, F., Moon, D. H., Carpenter, W. R., et al. (2017). Comparison of patient report and medical records of comorbidities: results from a population-based cohort of patients with prostate cancer. JAMA Oncology, 3(8), 1035–1042. https://doi.org/10.1001/jamaoncol.2016.6744
doi: 10.1001/jamaoncol.2016.6744 pubmed: 28208186 pmcid: 5824220
Bayliss, E. A., Ellis, J. L., & Steiner, J. F. (2009). Seniors’ self-reported multimorbidity captured biopsychosocial factors not incorporated into two other data-based morbidity measures. Journal of Clinical Epidemiology, 62(5), 550–7 e1. https://doi.org/10.1016/j.jclinepi.2008.05.002
doi: 10.1016/j.jclinepi.2008.05.002 pubmed: 18757178
Hall, E. T. S. S., Dickerson, J., Gaster, B., Wong, H., Aslaskson, R. A., & Schapira, L. (2019). Patient reported outcomes for cancer patients receiving immunotherapy: opportunies for palliative care- A systematic review. Jouranl of Pain and Symptom Management. https://doi.org/10.1200/JCO.2017.77.6385
doi: 10.1200/JCO.2017.77.6385
Brahmer, J. R. L. C., Schneider, B. J., Atkins, M. B., Brassil, K. J., Caterino, J. M., Cau, I., Ernstoof, M. S., Gardner, J. M., Ginex, P., & Hallmeyer, S. (2018). Treated with immune checkpoint inhibior thearapy: American society of clinical oncology practice guideline. Journal of Clinical Oncology, 36(17), 1714–1768. https://doi.org/10.12000/JCO.2017.77.6385
doi: 10.12000/JCO.2017.77.6385 pubmed: 29442540

Auteurs

Alla Sikorskii (A)

Department of Psychiatry, College of Osteopathic Medicine, Michigan State University, 909 Wilson Road, Road 321, East Lansing, MI, 48824, USA. sikorska@msu.edu.

Terry Badger (T)

College of Nursing, Department of Psychiatry and Mel and Enid Zuckerman College of Public Health, University of Arizona, 1305 N. Martin Avenue, Tucson, AZ, 85721, USA.

Chris Segrin (C)

Department of Communication, University of Arizona, Tucson, USA.

Tracy E Crane (TE)

Miller School of Medicine, Division of Medical Oncology, Sylvester Comprehensive Cancer Center, University of Miami, Coral Gables, USA.

Nathan Cunicelli (N)

University of Arizona, Tucson, USA.

Pavani Chalasani (P)

Division of Hematology-Oncology, George Washington University, Washington, DC, USA.

Waqas Arslan (W)

College of Medicine, University of Arizona, Phoenix, AZ, USA.

Charles Given (C)

College of Nursing, Michigan State University, East Lansing, USA.

Classifications MeSH